Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GB:0Q1G
Stock Latest News
The Fly
Eli Lilly announces FDA approves additional indication for Jaypirca
2d ago
LLY
Premium
The Fly
Wedbush downgrades Foghorn on end of Lilly collaboration
2d ago
LLY
FHTX
Premium
The Fly
Foghorn Therapeutics price target lowered to $5 from $12 at Guggenheim
2d ago
LLY
FHTX
Premium
The Fly
Foghorn Therapeutics downgraded at Citizens after FHD-909 discontinuation
3d ago
LLY
FHTX
Premium
The Fly
Foghorn Therapeutics price target lowered to $5 from $12 at Stifel
3d ago
LLY
FHTX
Premium
The Fly
Foghorn, Lilly to not advance FHD-909 program, Foghorn to reduce workforce
3d ago
LLY
FHTX
Premium
The Fly
Eli Lilly’s Foundayo shows reduction in type 2 diabetes and cardiovascular risk
3d ago
LLY
Premium
The Fly
Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study
4d ago
LLY
Premium
The Fly
Lilly says participants on EloraTZP lost up to average 23.3% of weight in study
4d ago
LLY
Premium
The Fly
Eli Lilly announces results of Phase 2b trial of EloraTZP
4d ago
LLY
Premium
Ratings
Evan Seigerman Reiterates Buy on Eli Lilly, Citing Strong Obesity/Diabetes Portfolio and Pipeline Momentum, Maintains $1400 Price Target
4d ago
LLY
Premium
The Fly
Eli Lilly says ebglyss met endpoints in Phase 3b ADtouch study
4d ago
LLY
Premium
The Fly
Eli Lilly reports results from TRIUMPH-2 Phase 3 trial
5d ago
LLY
Premium
The Fly
Eli Lilly’s Zepbound shows improved weight loss vs. Wegovy in new analysis
5d ago
LLY
Premium
The Fly
Eli Lilly announces positive results from study of Foundayo 17.2 mg
5d ago
LLY
Premium
The Fly
Eli Lilly CEO tells Bloomberg sees more deals in untapped areas
6d ago
LLY
Premium
The Fly
Eli Lilly price target raised to $1,500 from $1,400 at JPMorgan
6d ago
LLY
Premium
The Fly
Eli Lilly launches ‘Lilly Change the Course Commitment’
6d ago
LLY
Premium
The Fly
Nektar awarded $90M in Eli Lilly breach of contract case
7d ago
LLY
NKTR
Premium
The Fly
Nektar selloff on trial brings ‘strong entry point,’ says BTIG
7d ago
LLY
NKTR
Premium
The Fly
Eli Lilly announces FDA approval of Olumiant
9d ago
LLY
Premium
The Fly
Eli Lilly announces FDA approval of Onswik for type 2 diabetes
10d ago
LLY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
